HSR25-192: Evaluation of Alternative Approaches to New Lesion Management and Measurable Disease Size Threshold on RANO-BM Response Assessment Following SRS for Brain Metastases
"HSR25-192: Evaluation of Alternative Approaches to New Lesion Management and Measurable Disease Size Threshold on RANO-BM Response Assessment Following SRS for Brain Metastases" published on 28 Mar 2025 by National Comprehensive Cancer Network.
Authors
- Tatiana Kashtanova
- Naren Ramakrishna (ORCID: https://orcid.org/0000-0001-7544-7083)
- Andrew Keller
Institutions
- University of Central Florida (US)
- Johns Hopkins University (US)
- Orlando Health (US)
- Florida Hospital Cancer Institute (US)
- Florida College (US)
Publication Details
- Journal
- Journal of the National Comprehensive Cancer Network
- Published
- 2025-03-28
- DOI
- https://doi.org/10.6004/jnccn.2024.7267
- Primary Topic
- Radiopharmaceutical Chemistry and Applications
- Type
- article
- Field-Weighted Citation Impact
- 0.00